Structure Therapeutics, Inc. (GPCR)
49.93
+0.92
(+1.88%)
USD |
NASDAQ |
Aug 25, 11:40
Structure Therapeutics Price : 49.93 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 48.61 | 49.33 | 47.62 | 49.01 | 822246.0 |
| Aug 21, 2026 | 50.70 | 51.11 | 49.01 | 49.09 | 592574.0 |
| Aug 20, 2026 | 54.15 | 54.60 | 50.33 | 50.52 | 1.429M |
| Aug 19, 2026 | 54.30 | 55.35 | 52.40 | 54.13 | 710055.0 |
| Aug 18, 2026 | 53.70 | 55.60 | 52.58 | 53.53 | 687395.0 |
| Aug 17, 2026 | 54.00 | 54.66 | 53.00 | 53.76 | 305438.0 |
| Aug 14, 2026 | 54.61 | 54.99 | 52.81 | 54.51 | 555889.0 |
| Aug 13, 2026 | 53.91 | 55.00 | 52.57 | 54.70 | 444162.0 |
| Aug 12, 2026 | 52.55 | 53.92 | 51.00 | 53.91 | 1.509M |
| Aug 11, 2026 | 53.70 | 53.70 | 51.88 | 52.13 | 471769.0 |
| Aug 10, 2026 | 53.19 | 53.87 | 51.87 | 53.80 | 358693.0 |
| Aug 07, 2026 | 53.80 | 54.80 | 50.83 | 53.14 | 329496.0 |
| Aug 06, 2026 | 50.02 | 52.78 | 50.02 | 52.62 | 335508.0 |
| Aug 05, 2026 | 49.98 | 51.66 | 49.85 | 50.53 | 713610.0 |
| Aug 04, 2026 | 49.40 | 50.51 | 48.30 | 49.64 | 876827.0 |
| Aug 03, 2026 | 48.04 | 48.71 | 46.58 | 48.36 | 326381.0 |
| Jul 31, 2026 | 49.50 | 49.50 | 46.81 | 48.04 | 407589.0 |
| Jul 30, 2026 | 47.29 | 49.62 | 46.40 | 49.47 | 384071.0 |
| Jul 29, 2026 | 47.10 | 48.68 | 47.00 | 47.35 | 470394.0 |
| Jul 28, 2026 | 48.41 | 48.41 | 46.79 | 47.89 | 507631.0 |
| Jul 27, 2026 | 49.35 | 51.30 | 48.69 | 48.69 | 464406.0 |
| Jul 24, 2026 | 50.76 | 51.00 | 49.04 | 49.12 | 655410.0 |
| Jul 23, 2026 | 50.43 | 52.60 | 49.98 | 50.80 | 665366.0 |
| Jul 22, 2026 | 48.80 | 50.48 | 48.80 | 50.41 | 616804.0 |
| Jul 21, 2026 | 46.91 | 49.42 | 46.06 | 49.35 | 299298.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1259.40 |
| Novo Nordisk A/S | 48.19 |
| Pfizer Inc. | 28.48 |
| Tarsus Pharmaceuticals, Inc. | 71.99 |
| Johnson & Johnson | 272.93 |
Price Related Metrics
| Price to Book Value | 2.625 |
| Earnings Yield | -6.17% |
| Market Cap | 3.556B |